News · John B. Sanfilippo & Son, Inc. (JBSS) · Consumer Defensive

John B. Sanfilippo & Son falls after weak quarterly results and profit margin pressure

Session of October 29, 2026 · Published October 30, 2026 · 4 min read

What happened

John B. Sanfilippo & Son (JBSS) fell 14.9% on October 29, 2026, after fiscal first-quarter results missed expectations and showed margin deterioration. The quarterly release, reported by Business Wire and Seeking Alpha, cited pricing pressure, an unfavorable product mix and higher operating costs as the main drags on profit. Trading volume was elevated at 2.1 times its 20-day average as the market reacted to the report.

$60.00$65.00Sep 18Sep 29Oct 8Oct 20Oct 29JBSS closing price, last 30 sessionspromtfinance.com$56.47 (-14.9%)
Closing price over the last 30 trading sessions. On October 29, 2026, JBSS closed at $56.47, down 14.9% on the day and 16.1% lower than 30 sessions earlier.

How big was the move

The one-day drop was 5.7 times a typical daily move for the stock and was 15.7 percentage points worse than the Consumer Defensive sector median, which rose 0.8% on the day. The broader S&P 500 fell 0.3% on the session. Over the past five sessions the stock fell 17.3% while the S&P 500 rose 0.7%. The stock opened 5.3% below the previous close, reflecting heavy early selling, and its beta of 0.34 shows it tends to move less than the market.

-10%0%+10%Aug 6Sep 3Oct 1Oct 29JBSS daily moves, last 60 sessions2 std. dev. bandpromtfinance.com
Each bar is one day's price change; the outlined bar is October 29, 2026. A typical daily move over the past year was 2.0%, so the latest move equals 7.3 times that. Moves outside the dashed lines (about 4.1%) are unusual.

The technical picture

Technicals showed weakness across time frames. The stock sat 15.1% below its 20-day moving average, 18.2% below its 50-day average and 26.8% below its 200-day average. The 50-day average is below the 200-day average, a sign of a weak longer-term trend. Momentum indicators were negative: the relative strength index was 20, below the 30 threshold commonly called oversold, and the shares were 38.7% below their 52-week high. Price performance has deteriorated recently, with the stock down 15.1% over one month and 31.8% over three months. Volatility was elevated at 41% annualized over 60 days, a reading higher than 99% of its own five-year history.

$60.00$70.00$80.00$90.00Oct '25Jan '26May '26Jul '26Oct '26JBSS one-year price and moving averages200-day50-dayPricepromtfinance.com52-week high $90.6052-week low $56.47
Closing price over the past year. JBSS ends the period 37.7% below its 52-week high, below its 50-day average ($69.00) and below its 200-day average ($77.16).

Fundamentals and valuation

For the four quarters through September 24, 2026, revenue was $1.17 billion, up 3.1% from a year earlier, while diluted earnings per share were $4.77, down 15.3% year-over-year. Gross margin narrowed to 17.7% from 18.7% a year earlier and operating margin fell to 6.8% from 8.4%. Free-cash-flow margin was 2.6% and return on invested capital was 12.1%. The company carried net debt of 0.4 times EBITDA and its share count increased by 0.9% over one year.

$0.00$100M$200M$300MQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26JBSS quarterly revenuepromtfinance.com$301M$261M$269M$299M$315M$282M$280M$288M
Quarterly revenue by period end. The latest quarter brought $288M, 3.5% less than the same quarter a year earlier.

On valuation the stock traded at 11.8 times trailing earnings and 10.5 times forward earnings, with a free-cash-flow yield of 3.9%. Its price-to-trailing-earnings reading is lower than 95% of its own readings over the past five years, where the five-year median was 16.0 times earnings. Those figures point to modest revenue growth but deteriorating profitability; the compressed margins and lower EPS explain the market reaction, while the low trailing P/E helps explain why some commentators flagged valuation as a counterweight to the near-term weakness.

Earnings and analyst expectations

The company reported on October 28, 2026. On that date it posted earnings per share of $1.11 against $1.53 expected, 27.5% below estimates. In its filing for the period ended September 24, 2026, John B. Sanfilippo & Son disclosed net sales of $288.1 million, a decrease of $10.5 million or 3.5%. Sales volume was flat at 90.5 million pounds. Gross profit was $48.9 million, down 9.6%, and diluted EPS was $1.00, a 30.2% decline year-over-year. Those figures and related commentary were reported by Business Wire and Seeking Alpha.

$0.00$0.50$1.00$1.50Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26JBSS quarterly earnings per sharepromtfinance.com$1.16$1.72$1.15$1.60$1.53$1.43$0.70$1.11
Diluted earnings per share by quarter. The latest quarter shows $1.11, against $1.60 in the same quarter a year earlier.

Consecutive quarters beating estimates stood at zero and the average surprise over the last four reports was 7.7% below estimates. Historically the stock's typical two-day reaction after recent reports was a fall of 0.7%, making the latest move substantially larger. Management and analysts pointed to generally stable industry volume but said pricing, product mix and higher operating costs weighed on margins. They also noted the company is undertaking a production ramp for high-speed bar manufacturing; optimization and full shipments remain in progress, which could add near-term volatility to results.

Analyst coverage is light. Three analysts cover the stock, and all rate the stock Buy. The narrow coverage and unanimous Buy rating leave little road-testing of sentiment, despite the recent operational setbacks.

What to watch

  • October 28, 2026: quarterly release showing net sales $288.1 million, down $10.5 million or 3.5%, and diluted EPS $1.00, down 30.2% year-over-year (Business Wire; Seeking Alpha)
  • October 28, 2026: earnings per share $1.11 against $1.53 expected, 27.5% below estimates
  • November 4, 2026: next scheduled report date
  • Analysts with ratings: 3, with 100% reporting Buy and a consensus rating of Buy
  • PromtFinance scores: Value 88, Growth 34, Quality 70, Momentum 30, Revisions 33, Stability 59

Related stocks

More news from PromtFinance

Related stories from the last 48 hours

PSMTConsumer DefensiveOct 27PriceSmart falls 3.8% after earnings miss on weaker-than-expected EPSPriceSmart falls 3.8% after reporting fiscal results that missed EPS estimates, with sales growth and expansion plans noted.Read the analysis →COURConsumer DefensiveOct 30Coursera falls 25.5% after quarterly results and weak guidanceCoursera shares fell 25.5% after third-quarter results and fourth-quarter revenue guidance that disappointed some analysts.Read the analysis →CLConsumer DefensiveOct 30Colgate-Palmolive rises 2.3% after earnings beat and raised profitability outlookColgate-Palmolive rose 2.3% after third-quarter results beat estimates and the company raised its 2026 profitability outlook.Read the analysis →ACUConsumer DefensiveOct 27Acme United rises 3.5% after quarterly results beat estimates and cost-cutting newsAcme United rises 3.5% after Q3 results beat estimates and the company flagged facility closure savings; trading volume surged.Read the analysis →HSYConsumer DefensiveOct 30Hershey rises after Q3 results beat estimates but management flags demand and cost risksHershey rose 3.3% after Q3 earnings topped estimates; company reiterated 2027 sales guidance while warning on softer demand and higher ingredient costs.Read the analysis →MDLZConsumer DefensiveOct 30Mondelez rises 3.9% after third-quarter adjusted EPS beat and outlook reaffirmedMondelez rose 3.9% after third-quarter adjusted EPS beat estimates and management reaffirmed its 2026 outlook; trading volume was twice the 20-day average.Read the analysis →NOVEnergyOct 28NOV falls 6.2% after third-quarter results disappoint expectationsNOV fell 6.2% on heavy volume after third-quarter results that matched EPS estimates but showed weaker margins and bookings.Read the analysis →